跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 355 条关于
“ZE77-0273”
全部
355
临床试验
155
药物
191
机构
0
资讯
9
11个月前
Eilean Therapeutics Unveils ZE77-0273, Novel Pan-EGFR Inhibitor for Drug-Resistant NSCLC
2年前
Retifanlimab Plus Chemotherapy Improves Outcomes in Advanced Anal Cancer
2年前
Retifanlimab Plus Chemotherapy Improves PFS in Advanced Anal Cancer
2年前
Retifanlimab Plus Chemotherapy Extends Progression-Free Survival in Advanced Squamous Cell Anal Carcinoma
去年
Moderna's mRNA-1273 COVID-19 Vaccine Shows Promise in Phase 1 Trial, Advances to Phase 3 Testing
去年
Indapta's IDP-023 Shows Promise in Multiple Myeloma and Enhanced NK Cell Activity
去年
FDA Clears Avenzo Therapeutics' IND for AVZO-023, a Novel CDK4 Selective Inhibitor for Advanced Breast Cancer
去年
CARGO Therapeutics Advances Cell Therapy Pipeline with Firi-cel, CRG-023, and Novel Allogeneic Platform
5个月前
Orvida Pharma Reports Positive Phase 1a Safety Data for KM-023, First-in-Class TRPV3 Inhibitor for Olmsted Syndrome